Dispatches
Reporting, interviews and investigations. Conference coverage, regulatory decisions, and conversations with the people who actually make, test and prescribe these compounds.
Five pivotal trials, weight loss in bariatric-surgery territory, and a filing date. Meanwhile, the vials sold online are an entirely different product.
Read the dispatch →The agency's advisory committee recommended six of seven peptides for the 503A bulks list. The headlines called it approval. It isn't — and the last substance to clear this committee on the same margin is still waiting, four years on.
Read the dispatch →Also coming
What the numbers mean, and what their absence means.
Conversations with the people whose names are on the paperwork.
The wider field: what's measurable, what's marketing.